Position
Fidelity in Denali Therapeutics Inc.
Back to the book · All holders of DNLI
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $29.6M$19.20 → $25.72
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 6.1M | $100.7M | — | — | — | 0.0% |
| Q1 2026 | 4.58M | $87.8M | $19.20 | $12.3M | −$25.1M | 0.0% |
| Q2 2026 | 4.54M | $116.7M | $25.72 | $29.6M | −$759.1K | 0.0% |